Total medical devices industry M&A deals in April 2020 worth $99.82m were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 99.2% over the previous month and a drop of 97.4% when compared with the last 12-month average, which stood at $3.76bn.
Comparing deals value in different regions of the globe, Asia-Pacific held the top position, with total announced deals in the period worth $52.82m. At the country level, China topped the list in terms of deal value at $44.33m.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of M&A deals activity in April 2020 was the US with 13 deals, followed by Germany with four and the UK with three.
In 2020, as of the end of April 2020, medical devices M&A deals worth $13.88bn were announced globally, marking an increase of 53.3% year on year.
Medical devices industry M&A deals in April 2020: Top deals
The top five medical devices industry M&A deals accounted for 96.02% of the overall value during April 2020.
The combined value of the top five medical devices M&A deals stood at $95.85m, against the overall value of $99.82m recorded for the month.
The top five medical devices industry deals of April 2020 tracked by GlobalData were:
1) AK Medical International’s $40.2m acquisition of Beijing Libeier Biology Engineering Research Institute
2) The $39.64m acquisition of ApiFix by OrthoPediatrics
3) Essity Aktiebolag’s $6.98m acquisition of Novioscan Holdings
4) The $4.9m acquisition of N2CELL by Microtech
5) Huang Feipeng’s acquisition of Youshi Medical Technology Suzhou for $4.13m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.